Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ENOV | Common stock, par value $0.001 | +Grant/Award | $0 | +13,416 | +28.71% | $0.00 | 60,149 | Feb 27, 2023 | Direct | F1 |
transaction | ENOV | Common stock, par value $0.001 | -Sell | -$457,307 | -8,156 | -13.56% | $56.07 | 51,993 | Feb 27, 2023 | Direct | F2 |
transaction | ENOV | Common stock, par value $0.001 | +Grant/Award | $0 | +12,095 | +23.26% | $0.00 | 64,088 | Feb 28, 2023 | Direct | F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ENOV | Employee stock option (right to buy( | +Grant/Award | $0 | +28,681 | $0.00 | 28,681 | Feb 28, 2023 | Common stock, par value $0.001 | 28,681 | $57.62 | Direct | F4 |
Id | Content |
---|---|
F1 | Reflects the certification of the performance criteria for PRSUs previously awarded in 2020. For more details on the PRSUs, please refer to the "Outstanding Equity Awards at 2021 Fiscal Year-End" table on page 45 of Enovis Corporation's proxy statement as filed with the Securities and Exchange Commission on April 28, 2022. |
F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax withholding obligations relating to the vesting and deliver of certain restricted stock units and performance-based restricted units. |
F3 | This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. |
F4 | The option vests in three equal annual installments beginning on the first anniversary of the grant date. |